title: [Case of systemic Castleman's disease with hypothyroidism].
authors.forename: R
authors.initials: R
authors.lastname: Okubo
authors.forename: T
authors.initials: T
authors.lastname: Yoshida
authors.forename: T
authors.initials: T
authors.lastname: Kimura
authors.forename: K
authors.initials: K
authors.lastname: Okuma
authors.forename: E
authors.initials: E
authors.lastname: Morioka
authors.forename: S
authors.initials: S
authors.lastname: Kuno
authors.forename: K
authors.initials: K
authors.lastname: Tamura
authors.forename: A
authors.initials: A
authors.lastname: Suzumiya
authors.forename: Y
authors.initials: Y
authors.lastname: Tsuboi
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005871:Castleman Disease / Q000150:complications* / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000209:etiology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015850:Interleukin-6 / Q000097:blood; D008875:Middle Aged; D016878:POEMS Syndrome / Q000150:complications; D011239:Prednisolone / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D015850:Interleukin-6; D003520:Cyclophosphamide; D011239:Prednisolone